Literature DB >> 18537983

Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids.

M Weatherall1, K James, J Clay, K Perrin, M Masoli, M Wijesinghe, R Beasley.   

Abstract

OBJECTIVE: To determine the strength of association between the dose of inhaled corticosteroids (ICS) and risk of non-vertebral fracture in adults.
METHODS: A systematic review and meta-analysis of case-control studies of non-vertebral fractures in adults, in which at least two doses of ICS were reported as the dose of beclomethasone dipropionate (BDP) or equivalent.
RESULTS: Five case-control studies were identified, with a total of 43 783 cases and 259 936 controls. There was an association between the risk of non-vertebral fracture and increasing dose of BDP. The random-effects odds ratio of relative risk for a non-vertebral fracture was 1.12 (95% confidence interval 1.00-1.26) per 1000 microg increase in the daily dose of BDP or equivalent.
CONCLUSION: In older adults, the relative risk of non-vertebral fractures increases by about 12% for each 1000 microg/day increase in the dose of BDP or equivalent. The magnitude of this risk was considerably less than other common risk factors for fracture in the older adult.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18537983     DOI: 10.1111/j.1365-2222.2008.03029.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  21 in total

Review 1.  Meta-review: adverse effects of inhaled corticosteroids relevant to older patients.

Authors:  Katharina Mattishent; Menaka Thavarajah; Patricia Blanco; Daniel Gilbert; Andrew M Wilson; Yoon K Loke
Journal:  Drugs       Date:  2014-04       Impact factor: 9.546

Review 2.  Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?

Authors:  Andrea P Rossi; Erika Zanardi; Mauro Zamboni; Andrea Rossi
Journal:  Drugs Aging       Date:  2015-09       Impact factor: 3.923

3.  Erratum to: Safety Considerations of Inhaled Corticosteroids in the Elderly.

Authors:  Salvatore Battaglia; Irene Cardillo; Federico Lavorini; Mario Spatafora; Nicola Scichilone
Journal:  Drugs Aging       Date:  2015-12       Impact factor: 3.923

Review 4.  The Skeletal Effects of Inhaled Glucocorticoids.

Authors:  Stephanie A Sutter; Emily M Stein
Journal:  Curr Osteoporos Rep       Date:  2016-06       Impact factor: 5.096

Review 5.  Safety considerations of inhaled corticosteroids in the elderly.

Authors:  Salvatore Battaglia; Irene Cardillo; Federico Lavorini; Mario Spatafora; Nicola Scichilone
Journal:  Drugs Aging       Date:  2014-11       Impact factor: 3.923

Review 6.  Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  M Bradley Drummond; Elliott C Dasenbrook; Marshall W Pitz; David J Murphy; Eddy Fan
Journal:  JAMA       Date:  2008-11-26       Impact factor: 56.272

Review 7.  Withdrawal of inhaled corticosteroids in individuals with COPD--a systematic review and comment on trial methodology.

Authors:  Nighat J Nadeem; Stephanie J C Taylor; Sandra M Eldridge
Journal:  Respir Res       Date:  2011-08-12

8.  LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.

Authors:  Nanshan Zhong; Changzheng Wang; Xiangdong Zhou; Nuofu Zhang; Michael Humphries; Linda Wang; Chau Thach; Francesco Patalano; Donald Banerji
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-06-05

9.  Addition of Montelukast to Low-Dose Inhaled Corticosteroid Leads to Fewer Exacerbations in Older Patients Than Medium-Dose Inhaled Corticosteroid Monotherapy.

Authors:  Young Min Ye; Sang Ha Kim; Gyu Young Hur; Joo Hee Kim; Jung Won Park; Jae Jeong Shim; Ki Suck Jung; Hyun Young Lee; Hae Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2015-04-07       Impact factor: 5.764

Review 10.  Long-term therapy in COPD: any evidence of adverse effect on bone?

Authors:  Arnulf Langhammer; Siri Forsmo; Unni Syversen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.